Novel specific activity-based probes validate KLK proteases as druggable targets

Cancer Biol Ther. 2022 Dec 31;23(1):401-403. doi: 10.1080/15384047.2022.2074775.

Authors

Georgia Sotiropoulou¹, Eleni Zingkou¹, Georgios Pampalakis²

Affiliations

¹ Department of Pharmacy, School of Health Sciences, University of Patras, Rion-Patras, Greece.
² Department of Pharmacology-Pharmacognosy, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece.

No abstract available

Keywords: ABPs; KLK proteolytic cascades; KLK-ABPs; KLKs; activity-based probes; activography; kallikrein-related peptidases; theranostic ABPs.

Publication types

Letter
Comment

MeSH terms

Endopeptidases*
Humans
Peptide Hydrolases*

Substances

Endopeptidases
Peptide Hydrolases

Grants and funding

The author(s) reported there is no funding associated with the work featured in this article.